1. Home
  2. AWRE vs COEP Comparison

AWRE vs COEP Comparison

Compare AWRE & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • COEP
  • Stock Information
  • Founded
  • AWRE 1986
  • COEP 2017
  • Country
  • AWRE United States
  • COEP United States
  • Employees
  • AWRE N/A
  • COEP N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AWRE Technology
  • COEP Health Care
  • Exchange
  • AWRE Nasdaq
  • COEP Nasdaq
  • Market Cap
  • AWRE 35.2M
  • COEP 32.4M
  • IPO Year
  • AWRE 1996
  • COEP N/A
  • Fundamental
  • Price
  • AWRE $1.70
  • COEP $11.54
  • Analyst Decision
  • AWRE
  • COEP
  • Analyst Count
  • AWRE 0
  • COEP 0
  • Target Price
  • AWRE N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • AWRE 43.2K
  • COEP 136.7K
  • Earning Date
  • AWRE 03-11-2025
  • COEP 03-25-2025
  • Dividend Yield
  • AWRE N/A
  • COEP N/A
  • EPS Growth
  • AWRE N/A
  • COEP N/A
  • EPS
  • AWRE N/A
  • COEP N/A
  • Revenue
  • AWRE $16,966,000.00
  • COEP N/A
  • Revenue This Year
  • AWRE $10.98
  • COEP N/A
  • Revenue Next Year
  • AWRE N/A
  • COEP N/A
  • P/E Ratio
  • AWRE N/A
  • COEP N/A
  • Revenue Growth
  • AWRE N/A
  • COEP N/A
  • 52 Week Low
  • AWRE $1.35
  • COEP $2.31
  • 52 Week High
  • AWRE $2.97
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 56.48
  • COEP 59.40
  • Support Level
  • AWRE $1.60
  • COEP $8.65
  • Resistance Level
  • AWRE $1.75
  • COEP $13.70
  • Average True Range (ATR)
  • AWRE 0.10
  • COEP 2.11
  • MACD
  • AWRE 0.01
  • COEP -0.24
  • Stochastic Oscillator
  • AWRE 86.36
  • COEP 61.22

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: